ASCO 2016 - STORM trial update

  1. 255 Posts.
    lightbulb Created with Sketch. 35
    Looking forward to this ....

    Jun 05
    Sunday
    8:00 AM - 11:30 AM
    Location: Hall A
    POSTER SESSION
    Developmental Therapeutics—Immunotherapy
    Track(s): Developmental Therapeutics and Translational Research

    Abstract TPS3108
    Phase I STORM study (KEYNOTE 200): Intravenous delivery of a novel oncolytic immunotherapy agent, Coxsackievirus A21 in combination with pembrolizumab in advanced cancer patients.
    Poster Board: #423b
    Hardev S. Pandha, MD, PhD - Presenter
    University of Surrey

    https://iplanner.asco.org/am2016/#/session/11294
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.